• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎相关胆管癌中胆管周围干细胞龛的肿瘤转化。

Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.

机构信息

Department of Movement, Human and Health Sciences, Division of Health Sciences, University of Rome "Foro Italico", Rome, Italy.

Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.

出版信息

Hepatology. 2019 Feb;69(2):622-638. doi: 10.1002/hep.30210. Epub 2019 Jan 4.

DOI:10.1002/hep.30210
PMID:30102768
Abstract

Primary sclerosing cholangitis (PSC) is a chronic inflammatory cholangiopathy frequently complicated by cholangiocarcinoma (CCA). Massive proliferation of biliary tree stem/progenitor cells (BTSCs), expansion of peribiliary glands (PBGs), and dysplasia were observed in PSC. The aims of the present study were to evaluate the involvement of PBGs and BTSCs in CCA which emerged in PSC patients. Specimens from normal liver (n = 5), PSC (n = 20), and PSC-associated CCA (n = 20) were included. Samples were processed for histology, immunohistochemistry, and immunofluorescence. In vitro experiments were performed on human BTSCs, human mucinous primary CCA cell cultures, and human cholangiocyte cell lines (H69). Our results indicated that all CCAs emerging in PSC patients were mucin-producing tumors characterized by PBG involvement and a high expression of stem/progenitor cell markers. Ducts with neoplastic lesions showed higher inflammation, wall thickness, and PBG activation compared to nonneoplastic PSC-affected ducts. CCA showed higher microvascular density and higher expression of nuclear factor kappa B, interleukin-6, interleukin-8, transforming growth factor β, and vascular endothelial growth factor-1 compared to nonneoplastic ducts. CCA cells were characterized by a higher expression of epithelial-to-mesenchymal transition (EMT) traits and by the absence of primary cilia compared to bile ducts and PBG cells in controls and patients with PSC. Our in vitro study demonstrated that lipopolysaccharide and oxysterols (PSC-related stressors) induced the expression of EMT traits, the nuclear factor kappa B pathway, autophagy, and the loss of primary cilia in human BTSCs. Conclusion: CCA arising in patients with PSC is characterized by extensive PBG involvement and by activation of the BTSC niche in these patients, the presence of duct lesions at different stages suggests a progressive tumorigenesis.

摘要

原发性硬化性胆管炎(PSC)是一种慢性炎症性胆管病,常伴有胆管癌(CCA)。在 PSC 中观察到胆管树干/祖细胞(BTSC)大量增殖、周边胆管腺(PBG)扩张和发育不良。本研究旨在评估 PSC 患者中出现的 CCA 中 PBG 和 BTSC 的参与情况。纳入了正常肝脏(n=5)、PSC(n=20)和 PSC 相关 CCA(n=20)的标本。对标本进行了组织学、免疫组织化学和免疫荧光分析。在人 BTSC、人黏液性原发性 CCA 细胞培养物和人胆管细胞系(H69)上进行了体外实验。我们的结果表明,所有在 PSC 患者中出现的 CCA 都是黏液产生肿瘤,其特征是 PBG 参与和干细胞/祖细胞标志物高表达。与非肿瘤性 PSC 受累胆管相比,具有肿瘤病变的胆管表现出更高的炎症、壁厚度和 PBG 激活。与非肿瘤性 PSC 受累胆管相比,CCA 显示出更高的微血管密度和更高的核因子 kappa B、白细胞介素-6、白细胞介素-8、转化生长因子-β和血管内皮生长因子-1 的表达。与对照组和 PSC 患者的胆管和 PBG 细胞相比,CCA 细胞表现出更高的上皮-间充质转化(EMT)特征表达,并且缺乏初级纤毛。我们的体外研究表明,脂多糖和氧化固醇(PSC 相关应激物)诱导人 BTSC 中 EMT 特征、核因子 kappa B 途径、自噬和初级纤毛丧失的表达。结论:PSC 患者中发生的 CCA 具有广泛的 PBG 参与和这些患者中 BTSC 龛的激活,不同阶段的胆管病变的存在提示进行性肿瘤发生。

相似文献

1
Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.原发性硬化性胆管炎相关胆管癌中胆管周围干细胞龛的肿瘤转化。
Hepatology. 2019 Feb;69(2):622-638. doi: 10.1002/hep.30210. Epub 2019 Jan 4.
2
Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.原发性硬化性胆管炎发病机制和胆管癌发生中的胆管细胞。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1390-1400. doi: 10.1016/j.bbadis.2017.08.020. Epub 2017 Aug 25.
3
Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.原发性硬化性胆管炎中胆树干细胞在胆小管周围腺内的激活。
J Hepatol. 2015 Nov;63(5):1220-8. doi: 10.1016/j.jhep.2015.06.018. Epub 2015 Jun 25.
4
Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.原发性硬化性胆管炎终末期伴或不伴胆管癌的癌前胆管病变。
Am J Surg Pathol. 2010 Jan;34(1):27-34. doi: 10.1097/PAS.0b013e3181bc96f9.
5
Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.原发性硬化性胆管炎中逐步细胞学算法诊断胆道恶性肿瘤的诊断性能。
Liver Int. 2019 Feb;39(2):382-388. doi: 10.1111/liv.14007. Epub 2018 Dec 2.
6
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.基于液体活检的蛋白生物标志物用于胆管癌的风险预测、早期诊断和预后评估。
J Hepatol. 2023 Jul;79(1):93-108. doi: 10.1016/j.jhep.2023.02.027. Epub 2023 Mar 1.
7
Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.原发性硬化性胆管炎相关胆管癌的遗传和表观遗传异常。
Inflamm Bowel Dis. 2013 Jul;19(8):1789-97. doi: 10.1097/MIB.0b013e318281f49a.
8
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.原发性硬化性胆管炎中的胆管癌:K-ras 突变和 Tp53 功能障碍与肿瘤发生发展有关。
J Hepatol. 2000 Mar;32(3):374-80. doi: 10.1016/s0168-8278(00)80386-4.
9
Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.可疑刷检细胞学是原发性硬化性胆管炎进行肝移植评估的指征。
World J Gastroenterol. 2017 Sep 7;23(33):6147-6154. doi: 10.3748/wjg.v23.i33.6147.
10
p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.原发性硬化性胆管炎相关胆管癌中p53蛋白的过表达
Gut. 1996 Feb;38(2):265-8. doi: 10.1136/gut.38.2.265.

引用本文的文献

1
Cholangiocytes' primary cilia regulate DNA damage response and repair.胆管细胞的初级纤毛调节DNA损伤反应和修复。
Am J Physiol Gastrointest Liver Physiol. 2025 Sep 1;329(3):G469-G483. doi: 10.1152/ajpgi.00055.2025. Epub 2025 Aug 12.
2
Unique clinical, morphological, and molecular characteristics of tumors associated with PSC-IBD.与原发性硬化性胆管炎-炎症性肠病相关的肿瘤的独特临床、形态学和分子特征。
Virchows Arch. 2025 Apr;486(4):651-661. doi: 10.1007/s00428-025-04072-y. Epub 2025 Mar 19.
3
IL-8-NF-κB-ALDH1A1 loop promotes the progression of intrahepatic cholangiocarcinoma.
白细胞介素-8-核因子-κB-醛脱氢酶1A1环路促进肝内胆管癌进展。
Hepatol Commun. 2025 Feb 26;9(3). doi: 10.1097/HC9.0000000000000664. eCollection 2025 Mar 1.
4
Morphomolecular Pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma.胆管癌和肝细胞胆管癌起源细胞的形态分子病理学与基因组学见解
Am J Pathol. 2025 Mar;195(3):345-361. doi: 10.1016/j.ajpath.2024.08.014. Epub 2024 Sep 26.
5
Transposon-based oncogene integration in Abcb4(Mdr2) mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis.基于转座子的致癌基因整合在Abcb4(Mdr2)小鼠中重现了原发性硬化性胆管炎对胆管癌的高度易感性。
J Hepatol. 2025 Jan;82(1):84-96. doi: 10.1016/j.jhep.2024.07.016. Epub 2024 Jul 30.
6
Autophagy impairment in human bile duct carcinoma cells.人胆管癌细胞中的自噬损伤
Front Physiol. 2023 Sep 29;14:1249264. doi: 10.3389/fphys.2023.1249264. eCollection 2023.
7
Liver cell therapies: cellular sources and grafting strategies.肝细胞治疗:细胞来源和移植策略。
Front Med. 2023 Jun;17(3):432-457. doi: 10.1007/s11684-023-1002-1. Epub 2023 Jul 4.
8
Endoscopic Ultrasound in the Diagnosis of Extrahepatic Cholangiocarcinoma: What Do We Know in 2023?内镜超声在肝外胆管癌诊断中的应用:2023年我们了解多少?
Diagnostics (Basel). 2023 Mar 8;13(6):1023. doi: 10.3390/diagnostics13061023.
9
Cholangiocarcinoma: Molecular Abnormalities and Cells of Origin.胆管癌:分子异常与细胞起源。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221128689. doi: 10.1177/15330338221128689.
10
Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy.肝纤维化对接受吉西他滨化疗的肝内胆管癌患者生存的影响。
J Clin Med. 2022 Apr 6;11(7):2057. doi: 10.3390/jcm11072057.